Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-97-010888
Filing Date
1997-03-31
Accepted
1997-03-31 00:00:00
Documents
5
Period of Report
1996-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 10-K 10-K 200641
2 EXHIBIT 10.18IMPERIAL BANK DOCUMENT EX-10.18 85754
3 EXHIBIT 11.1; STATEMENT RE: COMPUTATION OF NET EX-11.1 3335
4 EXHIBIT 23.1 EX-23.1 788
5 FINANCIAL DATA SCHEDULE EX-27.1 2081
  Complete submission text file 0000912057-97-010888.txt   294507
Mailing Address 3031 RESEARCH DRIVE 3031 RESEARCH DRIVE RICHMOND CA 94806
Business Address 3031 RESEARCH DR BLDG A RICHMOND CA 94806 5102229700
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28298 | Film No.: 97568203
SIC: 2836 Biological Products, (No Diagnostic Substances)